Weempowerextraordinary
A passion for developing medicines for patients with complement-mediated and rare diseases
We are BioCryst.
A different kind of biotech company. A global company with over three decades of experience in drug discovery, development, and commercialization, guided by our passion for not settling for “ordinary” in our quest to develop novel medicines. We listen. We understand. We know that little things can make a big difference to patients.
We aim to deliver extraordinary first-in-class or best-in-class oral small-molecule and protein therapeutics for complement-mediated and other rare diseases. It’s what sets BioCryst apart – and what we strive to achieve. Our transparent and supportive culture transforms employees into owners, converts challenges into resilience, and empowers people to achieve beyond what they think is possible. Let’s connect >>
Meet Luke Robinson, our UK, Ireland, and Nordics General Manager
Welcome! BioCryst is a commercial-stage biotech company established over 35 years ago in Birmingham, Alabama, with a UK presence for the last 15 years. Quality of life for those with rare diseases such as hereditary angioedema (HAE) is what drives us and our culture, and I believe, is what sets us apart. Whether in the field or home office, our team in the UK is committed to living our values and to the patients we look to serve.